We reveal novel mechanisms, including Hnf–1α-mediated enhancement of intestinal sugar absorption, the first evidence of differential regulation of Tcf7l2, including its downregulation in skeletal muscle, and early islet reprogramming in WD models. Here, TCF7L2 is linked to Wilson disease.